Phocas Financial Corp’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-75,213
| Closed | -$4.37M | – | 163 |
|
|
2023
Q3 | $4.37M | Sell |
75,213
-72
| -0.1% | -$4.18K | 0.64% | 71 |
|
|
2023
Q2 | $4.05M | Sell |
75,285
-419
| -0.6% | -$22.6K | 0.55% | 79 |
|
|
2023
Q1 | $3.01M | Buy |
+75,704
| New | +$3.01M | 0.43% | 97 |
|
|
2020
Q1 | – | Sell |
-101,567
| Closed | -$6.26M | – | 188 |
|
|
2019
Q4 | $6.26M | Sell |
101,567
-25,633
| -20% | -$1.58M | 0.75% | 56 |
|
|
2019
Q3 | $9.27M | Sell |
127,200
-191
| -0.1% | -$13.9K | 0.99% | 29 |
|
|
2019
Q2 | $10.5M | Sell |
127,391
-13,586
| -10% | -$1.12M | 1.12% | 24 |
|
|
2019
Q1 | $9.95M | Buy |
140,977
+11,501
| +9% | +$811K | 1% | 35 |
|
|
2018
Q4 | $5.83M | Buy |
129,476
+32,671
| +34% | +$1.47M | 0.65% | 66 |
|
|
2018
Q3 | $5.47M | Buy |
96,805
+55,064
| +132% | +$3.11M | 0.48% | 93 |
|
|
2018
Q2 | $2.79M | Buy |
+41,741
| New | +$2.79M | 0.24% | 119 |
|